Key Points Interested in Oculis Holding AG? Here are five stocks we like better. Oculis' Phase 3 DIAMOND trials of OCS-01 in ...

OCS-01 failed to meet the primary endpoint of improving visual acuity in both Phase 3 DIAMOND studies. ・The treatment reduced ...

Diabetic macular edema is an eye condition that results as a complication of diabetes. It’s a type of diabetic retinopathy. This happens when high blood sugar damages the blood vessels in your retina, ...

The primary endpoint of mean change in best corrected visual acuity (BCVA) from baseline to week 52 in both Phase 3 trials was not met The ...

Diabetic macular edema (DME) is an eye condition that can lead to vision loss in people with diabetes. It occurs as a result of diabetic retinopathy — damaged blood vessels in the eyes due to elevated ...

Therini Bio, Inc., a clinical-stage biotech company developing fibrin-targeting immunotherapies for neurodegenerative diseases driven by vascular-mediated inflammation, today announced that the first ...

The optic cup and macula of a 24-year-old female. Image is released to Wikimedia commons with patient consent. Imaged with a non-mydriatic fundus camera at Pacific University College of Optometry.

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Diabetic macular edema (DME) is a possible complication of diabetes. It happens when the tiny blood vessels in the eye get damaged from high blood sugar levels over time. In the early stages, there ...

What are the early signs of diabetic macular edema? Early signs you may have diabetic macular edema include blurred vision, colors appearing faded or dull, and distorted vision where objects look wavy ...

Nicholas G. Anderson, MD, and Philip Niles, MD, MBA, provide an overview of diabetic macular edema (DME) and the impact of vision impairment on a patient’s quality of life. Jim Kenney, RPh, MBA: Dr.